Pharmacokinetics and interspecies scaling of recombinant human factor VIII

Toxicology and Applied Pharmacology

Volumn 136, Issue 1, 1996, Pages 75-78

  Mordenti, Joyce ^a   Osaka, Gary ^a   Garcia, Kit ^a   Thomsen, Karen ^a   Licko, Vojtech ^a   Meng, Gloria ^a  

^a GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT BLOOD CLOTTING FACTOR 8;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG CLEARANCE; DRUG DISPOSITION; DRUG DISTRIBUTION; DRUG HALF LIFE; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PHARMACOKINETICS; RAT; SPECIES DIFFERENCE;

EID: 0030040359     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1996.0008     Document Type: Article

References (19)

1. Boxenbaum, H. (1982). Interspecies scaling, allometry, physiological time, and the ground plan of pharmacokinetics. J. Pharmacokinet. Biopharm. 10, 201-227.
2. Chappell, W., and Mordenti, J. (1991). Extrapolation of toxicological and pharmacological data from animals to humans. In Advances in Drug Research, (B. Testa, Ed.), Vol. 20, pp. 1-116. Academic Press, San Diego.
3. Chiou, W. L., and Hsu, F. (1988). Correlation of unbound plasma clearances of fifteen extensively metabolised drugs between humans and rats. Pharm. Res. 5, 668-672.
4. Davidson, I. W. F., Parker, J. C., and Beliles, R. P. (1986). Biological basis for extrapolation across mammalian species. Reg. Toxicol. Pharmacol. 6, 211-237.
5. Dedrick, R., Bischoff, K., and Zaharko, D. (1970). Interspecies correlation of plasma concentration history of methotrexate (NSC-740). Cancer Chemother. Reports, Part 1 54, 95-101.
6. Eaton, D., Hass, P., Riddle, L., Mather, J., Wiebe, M., Gregory, T., and Vehar, G. (1987). Characterization of recombinant human factor VIII. J. Bio. Chem. 262, 3285-3290.
7. Fay, P. (1993). Factor VIII structure and function. Thromb. Haemost. (Stuttgart) 70, 63-67.
8. Hoyer, L. W. (1994). Hemophilia A. New Eng. J. Med. 330, 38-47.
9. Lusher, J. M., and Warrier, I. (1992). Hematology/oncology clinics of north america. Coagul. Dis. I. 16, 1021-1033.
10. Messori, A., Longo, G., Morfini, M., Cinotti, S., Filimberti, E., Giustarini, G., and Rossi Ferrini, P. (1988). Multi-variate analysis of factors governing the pharmacokinetics of exogenous factor VIII in haemophiliacs. Eur. J. Clin. Pharmacol. 35, 663-668.
11. Mordenti, J. (1986). Man versus beast: Pharmacokinetic scaling in mammals. J. Pharm. Sci. 75, 1028-1040.
12. Mordenti, J., and Chappell, W. (1989). The use of interspecies scaling in toxicokinetics. In Toxicokinetics and New Drug Development (A. Yacobi, J. Skelly, and V. Batra, Eds.), pp. 42-96. Pergamon, New York.
13. Mordenti, J., Chen, S., Moore, J., Ferraiolo, B., and Green, J. (1991). Interspecies scaling of clearance and volume of distribution data for five therapeutic proteins. Pharm. Res. 8, 1351-1359.
14. Morfini, M., Mannucci, P., Tenconi, P., Longo, G., Mazzucconi, M., Rodeghiero, F., Ciavarella, N., De Rosa, V., and Arter, A. (1993). Pharmacokinetics of monoclonally purified and recombinant factor VIII in patients with severe von Willebrand disease. Thromb. Haemost. (Stuttgart) 70, 270-272.
15. Schwartz, R., Abildgaard, C., Aledort, L., et al. (1990). Human recombinant DNA-derived antihemophilic factor (Factor VIII) in the treatment of hemophilia A. New Eng. J. Med. 1800-1805.
16. Vehar, G., Keyt, B., Eaton, D., Rodriquez, H., O'Brien, D., Rotblat, F., Oppermann, H., Keck, R., Wood, W., Harkins, R., Tuddenham, E., Lawn, R., and Capon, D. (1984). Structure of human factor VIII. Nature 312, 337-342.
17. Vehar, G., and Eaton, D. (1989). Factor VIII structure and function. In Coagulation and Bleeding Disorders: The Role of Factor VIII and von Willebrand Factor (T. S. Zimmerman and Z. Rugger, Eds.), pp. 1-21. Dekker, New York.
18. Wagner, J. G. (1976). Linear pharmacokinetic equations allowing direct calculation of many needed pharmacokinetic parameters from the coefficients and exponents of polyexponential equations which have been fitted to the data. J. Pharmacokin. Biopharm. 4, 443-467.
19. Wood, W., Capon, D., Simonsen, C., et al. (1984). Expression of active human factor VIII from recombinant DNA clones. Nature 312, 330-337.